- Home
- ELSE vs CANF Comparison
ELSE vs CANF Comparison
Compare ELSE & CANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELSE | CANF |
|---|---|---|
| Founded | 1968 | 1994 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.4M | 4.7M |
| IPO Year | 1995 | 2011 |
Fundamental Metrics
Financial Performance| Metric | ELSE | CANF |
|---|---|---|
| Price | $4.37 | $3.10 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9,750.00 |
| AVG Volume (30 Days) | 3.1K | ★ 38.3K |
| Earning Date | 05-11-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $10,142,000.00 | N/A |
| Revenue This Year | N/A | $2,715,455.50 |
| Revenue Next Year | N/A | $101.06 |
| P/E Ratio | $48.44 | ★ N/A |
| Revenue Growth | ★ 8.20 | N/A |
| 52 Week Low | $3.65 | $0.17 |
| 52 Week High | $5.29 | $10.40 |
Technical Indicators
Market Signals| Indicator | ELSE | CANF |
|---|---|---|
| Relative Strength Index (RSI) | 49.79 | 39.88 |
| Support Level | $4.08 | $0.59 |
| Resistance Level | $4.45 | $4.74 |
| Average True Range (ATR) | 0.10 | 0.18 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 41.94 | 32.09 |
Price Performance
Historical ComparisonAbout ELSE Electro-Sensors Inc.
Electro-Sensors Inc manufactures and sells industrial production monitoring and process control systems. It manufactures a complete line of monitoring and control systems for a wide range of industrial machine applications. The systems measure machine production and operation rates, as well as regulate the speed of related machines in production processes. Its products include motor drive control, position monitors, sensor targets, signal conditioners, speed sensors, speed switches, tachometers, temperature sensors, vibration monitors, etc.
About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)
Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.